Gordian Capital Singapore Pte LTD Viking Therapeutics, Inc. Transaction History
Gordian Capital Singapore Pte LTD
- $155 Million
- Q3 2024
A detailed history of Gordian Capital Singapore Pte LTD transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Gordian Capital Singapore Pte LTD holds 50 shares of VKTX stock, worth $1,744. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 800
93.75%
Holding current value
$1,744
Previous $42,000
92.86%
% of portfolio
0.0%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding VKTX
# of Institutions
469Shares Held
63.2MCall Options Held
5.76MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$355 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$210 Million0.01% of portfolio
-
State Street Corp Boston, MA4.67MShares$163 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.12MShares$73.8 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.87MShares$65.4 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.68B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...